Form 4 for DGX Quest Diagnostics
Accepted 2026-02-20 00:00:00 ET · period of report 2026-02-18 · accession 0001222679-26-000002 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2026-02-20 | 2026-02-18 | DGX | PREVOZNIK MICHAEL E | SVP, GC | F - Tax | $208.39 | -648 | 39.8K | -2% | -$135.0K |
| D | 2026-02-20 | 2026-02-18 | DGX | PREVOZNIK MICHAEL E | SVP, GC | A - Grant | $0.00 | +2,013 | 40.1K | +5% | $0 |
| D | 2026-02-20 | 2026-02-19 | DGX | PREVOZNIK MICHAEL E | SVP, GC | S - Sale | $204.83 | -1,111 | 38.4K | -3% | -$227.6K |
| D | 2026-02-20 | 2026-02-18 | DGX | PREVOZNIK MICHAEL E | SVP, GC | A - Grant | $0.00 | +9,289 | 9,289 | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-02-18 | F | D | 347 | $206.99 | 39,482 | D | — | — | (F2) Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the vesting of restricted stock units. |
| 2 | Common | Common Stock | 2026-02-18 | F | D | 301 | $210.01 | 39,829 | D | — | — | (F2) Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the vesting of restricted stock units. |
| 3 | Common | Common Stock | 2026-02-18 | A | A | 2,013 | $0.00 | 40,130 | D | — | — | (F1) Represents an award of restricted stock units. |
| 4 | Common | Common Stock | 2026-02-19 | S | D | 1,111 | $204.83 | 38,371 | D | — | — | (F3) This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person. |
| 5 | Derivative | Non-Qualifed Stock Option (right to buy) | 2026-02-18 | A | A | 9,289 | $0.00 | 9,289 | D | $204.96 · — to 2036-02-18 | 9,289 Common Stock | (F5) The options vest in three equal annual installments beginning on the first annual anniversary of the grant date. |